First Neandertal with Down Syndrome: Evidence of Altruistic Care in Prehistory

Click here to view original web page at First Neandertal with Down Syndrome: Evidence of Altruistic Care in Prehistory

Summary: A new study documents the first case of Down syndrome in a Neandertal child named “Tina,” found in Spain. Despite severe hearing loss and vertigo, Tina survived to at least 6 years old, indicating she received extensive care from her group. This discovery highlights the Neandertals’ capacity for […]

New Therapy Improves Cognition in Down Syndrome Patients

Click here to view original web page at New Therapy Improves Cognition in Down Syndrome Patients

There are a number of symptoms associated with Down syndrome (DS), which is caused by trisomy of chromosome 21, including intellectual disability and olfactory loss. A new treatment has been shown to improve cognitive function. In order to enhance the cognitive abilities of a small sample of Down syndrome […]

Issues With Fracture Healing in People With Down Syndrome

Click here to view original web page at Issues With Fracture Healing in People With Down Syndrome

Summary: Researchers report bone fractures in those with Down syndrome are unlikely to fully heal. Source: Texas A&M New research from the Texas A&M School of Veterinary Medicine & Biomedical Sciences (VMBS) is the first to provide direct experimental evidence that people with Down syndrome (DS) may not heal […]

Promising Alzheimer’s Drug May Also Improve Memory in Down Syndrome and Normal Aging

Click here to view original web page at Promising Alzheimer’s Drug May Also Improve Memory in Down Syndrome and Normal Aging

Summary: GM-CSF/sargramostim, a drug that improved memory in Alzheimer’s patients during a phase II clinical trial, also appears to improve cognitive function in older adults and those with Down syndrome. Source: University of Colorado A new study shows that a potential treatment for Alzheimer’s disease may also improve cognitive […]

Simple blood test can accurately reveal underlying neurodegeneration

Click here to view original web page at www.eurekalert.org

Levels of a protein called neurofilament light chain (NfL) in the blood can identify those who might have neurodegenerative diseases such as Down’s syndrome dementia, motor neuron disease (ALS) and frontotemporal dementia, when clinical symptoms are not definitive. Published in Nature Communications and part-funded by the NIHR Maudsley Biomedical […]

Why Do So Many People With Down Syndrome Develop Alzheimer’s Disease?

Click here to view original web page at www.technologynetworks.com

While medical advances and improvements of life quality have increased the life expectancy of people with Down’s syndrome to an average of 60 years, up to 90 percent develop Alzheimer’s disease if they live long enough. In Alzheimer’s disease, clumps of amyloid form plaques around the neurons of the […]

Brain Function in Unresponsive COVID-19; Down Syndrome Patients in Alzheimer’s Trials?

Click here to view original web page at www.medpagetoday.com

Despite prolonged unresponsiveness and structural brain injury, a 47-year-old patient with severe COVID-19 showed intact brain network function and eventually was able to follow commands. (Annals of Neurology) Iron concentration in deep gray matter and neocortical regions was higher in patients with Alzheimer’s disease than in healthy controls and […]

New therapeutic targets for treating memory impairment in Down syndrome

Click here to view original web page at www.eurekalert.org

Barcelona, 4th May, 2020. A team of researchers led by Dr. Victoria Puig from the Hospital del Mar Medical Research Institute (IMIM), which also involved the Centre for Genomic Regulation (CRG), has studied the neural basis of intellectual disability in mice with Down syndrome and has discovered that the […]

New therapeutic possibilities for treating intellectual disability in Down syndrome

Click here to view original web page at www.news-medical.net

A team of researchers led by Dr. Victoria Puig from the Hospital del Mar Medical Research Institute (IMIM), which also involved the Centre for Genomic Regulation (CRG), has studied the neural basis of intellectual disability in mice with Down syndrome and has discovered that the neural networks of brain […]

New therapeutic targets for treating memory impairment in Down’s syndrome

Click here to view original web page at medicalxpress.com

Credit: CC0 Public Domain A team of researchers led by Dr. Victoria Puig from the Hospital del Mar Medical Research Institute (IMIM), which also involved the Centre for Genomic Regulation (CRG), has studied the neural basis of intellectual disability in mice with Down’s syndrome and has discovered that the […]